Share this:
3
Polish researchers have embarked on a €2.75 million ($2.5 million) study aimed at developing a low-cost painkiller capsule based on CBD. The effort, called Onkokan, combines the resources of five Polish research institutions. It raised €2 million from EU funding with the remainder provided by private sources.